ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Decision Making in Structure-Based Drug Discovery: Visual Inspection of Docking Results

Cite this: J. Med. Chem. 2021, 64, 5, 2489–2500
Publication Date (Web):February 22, 2021
Copyright © 2021 American Chemical Society

    Article Views





    Other access options


    Abstract Image

    Molecular docking is a computational method widely used in drug discovery. Due to the inherent inaccuracies of molecular docking, visual inspection of binding modes is a crucial routine in the decision making process of computational medicinal chemists. Despite its apparent importance for medicinal chemistry projects, guidelines for the visual docking pose assessment have been hardly discussed in the literature. Here, we review the medicinal chemistry literature with the aim of identifying consistent principles for visual inspection, highlighting cases of its successful application, and discussing its limitations. In this context, we conducted a survey reaching experts in both academia and the pharmaceutical industry, which also included a challenge to distinguish native from incorrect poses. We were able to collect 93 expert opinions that offer valuable insights into visually supported decision-making processes. This perspective shall motivate discussions among experienced computational medicinal chemists and guide young scientists new to the field to stratify their compounds.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 105 publications.

    1. François Sindt, Anthony Seyller, Merveille Eguida, Didier Rognan. Protein Structure-Based Organic Chemistry-Driven Ligand Design from Ultralarge Chemical Spaces. ACS Central Science 2024, 10 (3) , 615-627.
    2. Måns Andreasson, Maxime Donzel, Alva Abrahamsson, Andreas Berner, Mara Doimo, Anna Quiroga, Anna Eriksson, Yu-Kai Chao, Jeroen Overman, Nils Pemberton, Sjoerd Wanrooij, Erik Chorell. Exploring the Dispersion and Electrostatic Components in Arene–Arene Interactions between Ligands and G4 DNA to Develop G4-Ligands. Journal of Medicinal Chemistry 2024, 67 (3) , 2202-2219.
    3. Tiejun Dong, Ziduo Yang, Jun Zhou, Calvin Yu-Chian Chen. Equivariant Flexible Modeling of the Protein–Ligand Binding Pose with Geometric Deep Learning. Journal of Chemical Theory and Computation 2023, 19 (22) , 8446-8459.
    4. Somaya A. Abdel-Rahman, Valerij Talagayev, Szymon Pach, Gerhard Wolber, Moustafa T. Gabr. Discovery of Small-Molecule TIM-3 Inhibitors for Acute Myeloid Leukemia Using Pharmacophore-Based Virtual Screening. Journal of Medicinal Chemistry 2023, 66 (16) , 11464-11475.
    5. Althea T. Hansel-Harris, Diogo Santos-Martins, Niccolò Bruciaferri, Andreas F. Tillack, Matthew Holcomb, Stefano Forli. Ringtail: A Python Tool for Efficient Management and Storage of Virtual Screening Results. Journal of Chemical Information and Modeling 2023, 63 (7) , 1858-1864.
    6. Christian Kersten, Steven Clower, Fabian Barthels. Hic Sunt Dracones: Molecular Docking in Uncharted Territories with Structures from AlphaFold2 and RoseTTAfold. Journal of Chemical Information and Modeling 2023, 63 (7) , 2218-2225.
    7. Jinshan Nan, Jingming Liu, Guifeng Lin, Shanshan Zhang, Anjie Xia, Pei Zhou, Yangli Zhou, Jiahao Zhang, Jinlong Zhao, Shiyu Zhang, Chong Huang, Yifei Wang, Qian Hu, Junxian Chen, Mingli Xiang, Xin Yang, Shengyong Yang. Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain. Journal of Medicinal Chemistry 2023, 66 (5) , 3460-3483.
    8. Andreas Wasilewicz, Benjamin Kirchweger, Denisa Bojkova, Marie Jose Abi Saad, Julia Langeder, Matthias Bütikofer, Sigrid Adelsberger, Ulrike Grienke, Jindrich Cinatl Jr., Olivier Petermann, Leonardo Scapozza, Julien Orts, Johannes Kirchmair, Holger F. Rabenau, Judith M. Rollinger. Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach. Journal of Natural Products 2023, 86 (2) , 264-275.
    9. Zhipeng Yu, Yingxue Wang, David Shuian, Jingbo Liu, Wenzhu Zhao. Identification and Molecular Mechanism of Novel Immunomodulatory Peptides from Gelatin Hydrolysates: Molecular Docking, Dynamic Simulation, and Cell Experiments. Journal of Agricultural and Food Chemistry 2023, 71 (6) , 2924-2934.
    10. Sebastian Schieferdecker, Esther Vock. Development of Pharmacophore Models for the Important Off-Target 5-HT2B Receptor. Journal of Medicinal Chemistry 2023, 66 (2) , 1509-1521.
    11. Wenlang Liu, Zhenhao Liu, Hao Liu, Lance M. Westerhoff, Zheng Zheng. Free Energy Calculations Using the Movable Type Method with Molecular Dynamics Driven Protein–Ligand Sampling. Journal of Chemical Information and Modeling 2022, 62 (22) , 5645-5665.
    12. Min Xu, Cheng Shen, Jincai Yang, Qing Wang, Niu Huang. Systematic Investigation of Docking Failures in Large-Scale Structure-Based Virtual Screening. ACS Omega 2022, 7 (43) , 39417-39428.
    13. Melisa E. Gantner, Denis N. Prada Gori, Manuel A. Llanos, Alan Talevi, Andrea Angeli, Daniela Vullo, Claudiu T. Supuran, Luciana Gavernet. Identification of New Carbonic Anhydrase VII Inhibitors by Structure-Based Virtual Screening. Journal of Chemical Information and Modeling 2022, 62 (19) , 4760-4770.
    14. Elisabeth Kallert, Tim R. Fischer, Simon Schneider, Maike Grimm, Mark Helm, Christian Kersten. Protein-Based Virtual Screening Tools Applied for RNA–Ligand Docking Identify New Binders of the preQ1-Riboswitch. Journal of Chemical Information and Modeling 2022, 62 (17) , 4134-4148.
    15. Piermichele Kobauri, Nicole S. Galenkamp, Albert M. Schulte, Jisk de Vries, Nadja A. Simeth, Giovanni Maglia, Sebastian Thallmair, Dušan Kolarski, Wiktor Szymanski, Ben L. Feringa. Hypothesis-Driven, Structure-Based Design in Photopharmacology: The Case of eDHFR Inhibitors. Journal of Medicinal Chemistry 2022, 65 (6) , 4798-4817.
    16. Luca Andrade, Aline Albuquerque, Andrielly Santos-Costa, Disraeli Vasconcelos, Wilson Savino, Geraldo Rodrigues Sartori, João Herminio Martins Da Silva. Investigation of Unprecedented Sites and Proposition of New Ligands for Programmed Cell Death Protein I through Molecular Dynamics with Probes and Virtual Screening. Journal of Chemical Information and Modeling 2022, 62 (5) , 1236-1248.
    17. Andreas Luttens, Hjalmar Gullberg, Eldar Abdurakhmanov, Duy Duc Vo, Dario Akaberi, Vladimir O. Talibov, Natalia Nekhotiaeva, Laura Vangeel, Steven De Jonghe, Dirk Jochmans, Janina Krambrich, Ali Tas, Bo Lundgren, Ylva Gravenfors, Alexander J. Craig, Yoseph Atilaw, Anja Sandström, Lindon W. K. Moodie, Åke Lundkvist, Martijn J. van Hemert, Johan Neyts, Johan Lennerstrand, Jan Kihlberg, Kristian Sandberg, U. Helena Danielson, Jens Carlsson. Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses. Journal of the American Chemical Society 2022, 144 (7) , 2905-2920.
    18. Jigang Fan, Yaqin Liu, Ren Kong, Duan Ni, Zhengtian Yu, Shaoyong Lu, Jian Zhang. Harnessing Reversed Allosteric Communication: A Novel Strategy for Allosteric Drug Discovery. Journal of Medicinal Chemistry 2021, 64 (24) , 17728-17743.
    19. Christian Bailly, Corentin Bedart, Gérard Vergoten. A molecular docking exploration of the large extracellular loop of tetraspanin CD81 with small molecules. In Silico Pharmacology 2024, 12 (1)
    20. Thais Batista Fernandes, Rosania Yang, Glaucio Monteiro Ferreira, Priscila Oliveira de Souza, Vitor Galvão Lopes, Mônica Franco Zannini Junqueira Toledo, Gabriela Gonçalves Roliano, Gabriela Nogueira Debom, Sandra Valeria Vassiliades, Neuza Mariko Aymoto Hassimotto, Mario Hiroyuki Hirata, Elizandra Braganhol, Roberto Parise-Filho. Aryl-isoquinoline as a Potential Scaffold for Novel Antitumor Agents against Glioblastoma Cells. Letters in Drug Design & Discovery 2024, 21 (5) , 948-960.
    21. Asuka A. Orr, Alexander D. MacKerell Jr. Site‐Identification by Ligand Competitive Saturation as a Paradigm of Co‐solvent MD Methods. 2024, 83-118.
    22. Zhipeng Yu, Hong Lv, Mingjie Zhou, Pengcheng Fu, Wenzhu Zhao. Identification and molecular docking of tyrosinase inhibitory peptides from allophycocyanin in Spirulina platensis . Journal of the Science of Food and Agriculture 2024, 104 (6) , 3648-3653.
    23. Gérard Vergoten, Christian Bailly. Insights into the Mechanism of Action of the Degraded Limonoid Prieurianin. International Journal of Molecular Sciences 2024, 25 (7) , 3597.
    24. Na Liu, Yucen Tao, Peng Zhan, Xinyong Liu, Yuning Song. Discovery of new inhibitors of Cdc25B phosphatases by molecular docking-based virtual screening. Journal of Molecular Structure 2024, 1299 , 137161.
    25. Shuai Zhao, Shuang Ma, Yuanyue Zhang, Ming Gao, Zhenyu Luo, Shengbao Cai. Combining molecular docking and molecular dynamics simulation to discover four novel umami peptides from tuna skeletal myosin with sensory evaluation validation. Food Chemistry 2024, 433 , 137331.
    26. Juanjuan Su, Hao Wu, Chengying Yin, Fengchao Zhang, Feng Han, Wengong Yu. The hydrophobic cluster on the surface of protein is the key structural basis for the SDS-resistance of chondroitinase VhChlABC. Marine Life Science & Technology 2024, 6 (1) , 93-101.
    27. Elisabeth Kallert, Laura Almena Rodriguez, Jan-Åke Husmann, Kathrin Blatt, Christian Kersten. Structure-based virtual screening of unbiased and RNA-focused libraries to identify new ligands for the HCV IRES model system. RSC Medicinal Chemistry 2024, 6
    28. Sophia Clune, Paul Awolade, Qiong Zhou, Hector Esquer, Brock Matter, Jeffrey T. Kearns, Timothy Kellett, Damilola Caleb Akintayo, Uday B. Kompella, Daniel V. LaBarbera. The validation of new CHD1L inhibitors as a therapeutic strategy for cancer. Biomedicine & Pharmacotherapy 2024, 170 , 116037.
    29. Evgeny Gutkin, Filipp Gusev, Francesco Gentile, Fuqiang Ban, S. Benjamin Koby, Chamali Narangoda, Olexandr Isayev, Artem Cherkasov, Maria G. Kurnikova. In silico screening of LRRK2 WDR domain inhibitors using deep docking and free energy simulations. Chemical Science 2024, 6
    30. Rui Qin, Hao Zhang, Weifeng Huang, Zhenglin Shao, Jinping Lei. Deep learning-based design and screening of benzimidazole-pyrazine derivatives as adenosine A 2B receptor antagonists. Journal of Biomolecular Structure and Dynamics 2023, 2020 , 1-17.
    31. Benjamin Weiser, Jérôme Genzling, Mihai Burai-Patrascu, Ophélie Rostaing, Nicolas Moitessier. Machine learning-augmented docking. 1. CYP inhibition prediction. Digital Discovery 2023, 2 (6) , 1841-1849.
    32. Feng Kuang, Tao Xiang. Molecular mechanism of Acanthopanax senticosus in the treatment of Alzheimer’s disease based on network pharmacology and molecular docking. Molecular Diversity 2023, 27 (6) , 2849-2865.
    33. Paola Briseño-Díaz, Michael Schnoor, Martiniano Bello-Ramirez, Jose Correa-Basurto, Arturo Rojo-Domínguez, Leticia Arregui, Libia Vega, Enrique Núñez-González, Luis Andres Palau-Hernández, Carlos Guadalupe Parra-Torres, Óscar Manuel García Córdova, Ernesto Zepeda-Castilla, Eduardo Torices-Escalante, Leticia Domínguez-Camacho, Beatriz Xoconostle-Cazares, Marco Antonio Meraz-Ríos, Sandra Delfín-Azuara, Dayan Andrea Carrión-Estrada, Nicolas Villegas-Sepúlveda, Rosaura Hernández-Rivas, Maria del Rocio Thompson-Bonilla, Miguel Vargas. Synergistic effect of antagonists to KRas4B/PDE6 molecular complex in pancreatic cancer. Life Science Alliance 2023, 6 (12) , e202302019.
    34. Sergio Ramos, Alba Vicente-Blázquez, Marta López-Rubio, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez. Frentizole, a Nontoxic Immunosuppressive Drug, and Its Analogs Display Antitumor Activity via Tubulin Inhibition. International Journal of Molecular Sciences 2023, 24 (24) , 17474.
    35. Emre Aktaş, İrem Saygılı, Elif Kahveci, Zeynep Tekbıyık, Nehir Özdemir Özgentürk. Bioinformatic investigation of Nipah virus surface protein mutations: Molecular docking with Ephrin B2 receptor, molecular dynamics simulation, and structural impact analysis. Microbiology and Immunology 2023, 67 (12) , 501-513.
    36. Katarzyna Witoszka, Joanna Matalińska, Aleksandra Misicka, Piotr F. J. Lipiński. Moving out of CF 3 ‐Land: Synthesis, Receptor Affinity, and in silico Studies of NK1 Receptor Ligands Containing a Pentafluorosulfanyl (SF 5 ) Group. ChemMedChem 2023, 18 (23)
    37. Laura Calvo‐Barreiro, Valerij Talagayev, Szymon Pach, Somaya A. Abdel‐Rahman, Gerhard Wolber, Moustafa T. Gabr. Discovery of ICOS‐Targeted Small Molecules Using Pharmacophore‐Based Screening. ChemMedChem 2023, 18 (23)
    38. Hongyan Du, Dejun Jiang, Odin Zhang, Zhenxing Wu, Junbo Gao, Xujun Zhang, Xiaorui Wang, Yafeng Deng, Yu Kang, Dan Li, Peichen Pan, Chang-Yu Hsieh, Tingjun Hou. A flexible data-free framework for structure-based de novo drug design with reinforcement learning. Chemical Science 2023, 14 (43) , 12166-12181.
    39. Jacqueline Kuan, Mariia Radaeva, Adeline Avenido, Artem Cherkasov, Francesco Gentile. Keeping pace with the explosive growth of chemical libraries with structure‐based virtual screening. WIREs Computational Molecular Science 2023, 13 (6)
    40. Arslan R. Shaimardanov, Dmitry A. Shulga, Vladimir A. Palyulin. On importance of explicit account of non-complementary contacts in scoring functions. Mendeleev Communications 2023, 33 (6) , 802-805.
    41. Chao Liu, Wenqiang Cui, Kongfu Zhu, Shuguang Yuan, Liang Sun, Yujie Liang, Jianping Lu, Da Li, Zhiqin Deng, Li Duan, Weiming Zhang, Xiaohai Yu, Daping Wang, Huawei Zhang. Inhibitor screening for volume-sensitive LRRC8A chloride channel. Journal of Biomolecular Structure and Dynamics 2023, 225 , 1-9.
    42. Jie Yu, Zhaojun Li, Geng Chen, Xiangtai Kong, Jie Hu, Dingyan Wang, Duanhua Cao, Yanbei Li, Ruifeng Huo, Gang Wang, Xiaohong Liu, Hualiang Jiang, Xutong Li, Xiaomin Luo, Mingyue Zheng. Computing the relative binding affinity of ligands based on a pairwise binding comparison network. Nature Computational Science 2023, 3 (10) , 860-872.
    43. Shradheya R. R. Gupta, Tram M. Ta, Maryam Khan, Archana Singh, Indrakant K. Singh, Bela Peethambaran. Identification and validation of a small molecule targeting ROR1 for the treatment of triple negative breast cancer. Frontiers in Cell and Developmental Biology 2023, 11
    44. Moumita Ghosh, Shikha Raghav, Puja Ghosh, Swagatam Maity, Kavery Mohela, Deepti Jain. Structural analysis of novel drug targets for mitigation of Pseudomonas aeruginosa biofilms. FEMS Microbiology Reviews 2023, 47 (5)
    45. Lucianna H. Santos, Rafael E. O. Rocha, Diego L. Dias, Beatriz M. R. M. Ribeiro, Mateus Sá M. Serafim, Jônatas S. Abrahão, Rafaela S. Ferreira. Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays. Pharmaceuticals 2023, 16 (9) , 1319.
    46. Mounika Badineni, Vasavi Malkhed, Lavanya Rumandla, Ramesh Malikanti, Rajender Vadija, Kiran Kumar Mustyala. Structure Elucidation and Identification of Novel Lead Molecules against Sulfur Import Protein cysA of Mycobacterium tuberculosis. Current Protein & Peptide Science 2023, 24 (7) , 589-609.
    47. Shourya Podduturi, Divya Vemula, Siva Singothu, Vasundhra Bhandari. In-silico investigation of E8 surface protein of the monkeypox virus to identify potential therapeutic agents. Journal of Biomolecular Structure and Dynamics 2023, 37 , 1-14.
    48. Isra M. Alsaady, Leena H. Bajrai, Thamir A. Alandijany, Hattan S. Gattan, Mai M. El-Daly, Sarah A. Altwaim, Rahaf T. Alqawas, Vivek Dhar Dwivedi, Esam I. Azhar. Cheminformatics Strategies Unlock Marburg Virus VP35 Inhibitors from Natural Compound Library. Viruses 2023, 15 (8) , 1739.
    49. Piermichele Kobauri, Frank J. Dekker, Wiktor Szymanski, Ben L. Feringa. Rational Design in Photopharmacology with Molecular Photoswitches. Angewandte Chemie International Edition 2023, 62 (30)
    50. Piermichele Kobauri, Frank J. Dekker, Wiktor Szymanski, Ben L. Feringa. Rational Design in Photopharmacology with Molecular Photoswitches. Angewandte Chemie 2023, 135 (30)
    51. Menghan Gao, Dongwei Kang, Na Liu, Yanna Liu. In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease. Molecules 2023, 28 (14) , 5320.
    52. Vagelis Rinotas, Fotini Liepouri, Maria-Dimitra Ouzouni, Niki Chalkidi, Christos Papaneophytou, Mariza Lampropoulou, Veroniki P. Vidali, George Kontopidis, Elias Couladouros, Elias Eliopoulos, Athanasios Papakyriakou, Eleni Douni. Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis Inhibitors. International Journal of Molecular Sciences 2023, 24 (14) , 11290.
    53. Amel Elbasyouni, Stephen Wilson Kpordze, Hadil Suliman Hussein, Oumarou Soro, Samuel Mulondo, Jonas Nshimirimana, Tekeba Sisay Melese. The Crosstalk between Phytotherapy and Bioinformatics in the Management of Cancer. 2023
    54. Kerlen T. Korbeld, Maximilian J. L. J. Fürst. Curse and Blessing of Non‐Proteinogenic Parts in Computational Enzyme Engineering. ChemBioChem 2023, 24 (12)
    55. Bharat Kale, Austin Clyde, Maoyuan Sun, Arvind Ramanathan, Rick Stevens, Michael E. Papka. ChemoGraph: Interactive Visual Exploration of the Chemical Space. Computer Graphics Forum 2023, 42 (3) , 13-24.
    56. Sikang Chen, Jian Gao, Jiexuan Chen, Yufeng Xie, Zheyuan Shen, Lei Xu, Jinxin Che, Jian Wu, Xiaowu Dong. ClusterX: a novel representation learning-based deep clustering framework for accurate visual inspection in virtual screening. Briefings in Bioinformatics 2023, 24 (3)
    57. Bhrugesh Pravinchandra Joshi, Vishwambhar Vishnu Bhandare, Prittesh Patel, Abhishek Sharma, Rajesh Patel, Ramar Krishnamurthy. Molecular modelling studies and identification of novel phytochemical inhibitor of DLL3. Journal of Biomolecular Structure and Dynamics 2023, 41 (7) , 3089-3109.
    58. Ossama Daoui, Souad Elkhattabi, Samir Chtita. Design and Prediction of ADME/Tox Properties of Novel Magnolol Derivatives as Anticancer Agents for NSCLC Using 3D-QSAR, Molecular Docking, MOLCAD and MM-GBSA Studies. Letters in Drug Design & Discovery 2023, 20 (5) , 545-569.
    59. Shopnil Akash, Arafat Hossain, Nobendu Mukerjee, Md. Moklesur Rahman Sarker, Mohammad Firoz Khan, Md. Jamal Hossain, Mohammad A. Rashid, Ajoy Kumer, Arabinda Ghosh, Darwin A. León-Figueroa, Joshuan J. Barboza, Bijaya Kumar Padhi, Ranjit Sah. Modified coptisine derivatives as an inhibitor against pathogenic Rhizomucor miehei, Mycolicibacterium smegmatis (Black Fungus), Monkeypox, and Marburg virus by molecular docking and molecular dynamics simulation-based drug design approach. Frontiers in Pharmacology 2023, 14
    60. Xu Wang, ZiQiao Yu, Fuxiang Dong, Jinjian Li, Ping Niu, Qiyi Ta, JunMing Kan, Chunyu Ma, Moxuan Han, Junchao Yu, Dexi Zhao, Jinhua Li. Clarifying the mechanism of apigenin against blood–brain barrier disruption in ischemic stroke using systems pharmacology. Molecular Diversity 2023, 141
    61. Anna Paula de Castro Teixeira, Gustavo Fernandes Queiroga Moraes, Romário Jonas de Oliveira, Cosme Silva Santos, Rodrigo Ribeiro Alves Caiana, Juliano Carlo Rufino de Freitas, Ulrich Vasconcelos, Fillipe de Oliveira Pereira, Igara Oliveira Lima. Antifungal Activity, Antibiofilm and Association Studies with O ‐Alkylamidoximes against Cryptococcus spp.. Chemistry & Biodiversity 2023, 20 (3)
    62. Qilang Liang, Bangshun Luo. Visual inspection intelligent robot technology for large infusion industry. Open Computer Science 2023, 13 (1)
    63. F. Gentile, T. I. Oprea, A. Tropsha, A. Cherkasov. Surely you are joking, Mr Docking!. Chemical Society Reviews 2023, 52 (3) , 872-878.
    64. Jeff Blaney, Andrew M. Davis. Structure-based Design for Medicinal Chemists. 2023, 137-187.
    65. Joanna Matalińska, Piotr F.J. Lipiński. Docking is not enough: 17-trifluoromethylphenyl trinor PGF2α is only a very weak ligand of neurokinin-1 receptor. Experimental and Molecular Pathology 2023, 129 , 104849.
    66. Kaili Wang, Renyi Zhou, Yifan Wu, Min Li. RLBind: a deep learning method to predict RNA–ligand binding sites. Briefings in Bioinformatics 2023, 24 (1)
    67. Zechen Wang, Liangzhen Zheng, Sheng Wang, Mingzhi Lin, Zhihao Wang, Adams Wai-Kin Kong, Yuguang Mu, Yanjie Wei, Weifeng Li. A fully differentiable ligand pose optimization framework guided by deep learning and a traditional scoring function. Briefings in Bioinformatics 2023, 24 (1)
    68. Krystel El Hage, Nicolas Babault, Olek Maciejak, Bénédicte Desforges, Pierrick Craveur, Emilie Steiner, Juan Carlos Rengifo-Gonzalez, Hélène Henrie, Marie-Jeanne Clement, Vandana Joshi, Ahmed Bouhss, Liya Wang, Cyril Bauvais, David Pastré. Targeting RNA:protein interactions with an integrative approach leads to the identification of potent YBX1 inhibitors. eLife 2023, 12
    69. Xin-heng He, Chong-zhao You, Hua-liang Jiang, Yi Jiang, H. Eric Xu, Xi Cheng. AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors. Acta Pharmacologica Sinica 2023, 44 (1) , 1-7.
    70. Arti Gupta, Viney Lather, Dushyanth R. Vennapu, Sandeep Kumar, Mallikarjun. B.P., Neerupma Dhiman, Archana Sharma. 3D-QSAR, E-pharmacophore and molecular docking to explore substituted sulfonamides as carbonic anhydrase inhibitors in epilepsy. Research Journal of Pharmacy and Technology 2022, , 5521-5528.
    71. Dmitry A. Shulga, Konstantin V. Kudryavtsev. Theoretical Studies of Leu-Pro-Arg-Asp-Ala Pentapeptide (LPRDA) Binding to Sortase A of Staphylococcus aureus. Molecules 2022, 27 (23) , 8182.
    72. Hui Zhu, Yulin Zhang, Wei Li, Niu Huang. A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years. International Journal of Molecular Sciences 2022, 23 (24) , 15961.
    73. Larisa Ivanova, Mati Karelson. The Impact of Software Used and the Type of Target Protein on Molecular Docking Accuracy. Molecules 2022, 27 (24) , 9041.
    74. Jiahua Rao, Shuangjia Zheng, Yutong Lu, Yuedong Yang. Quantitative evaluation of explainable graph neural networks for molecular property prediction. Patterns 2022, 3 (12) , 100628.
    75. Måns Andréasson, Naresh Bhuma, Nils Pemberton, Erik Chorell. Using Macrocyclic G‐Quadruplex Ligands to Decipher the Interactions Between Small Molecules and G‐Quadruplex DNA. Chemistry – A European Journal 2022, 28 (65)
    76. Isabella Romeo, Francesca Alessandra Ambrosio, Giosuè Costa, Angela Corona, Mohammad Alkhatib, Romina Salpini, Saverio Lemme, Davide Vergni, Valentina Svicher, Maria Mercedes Santoro, Enzo Tramontano, Francesca Ceccherini-Silberstein, Anna Artese, Stefano Alcaro. Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach. Molecules 2022, 27 (21) , 7522.
    77. Benjamin Kirchweger, Andreas Wasilewicz, Katrin Fischhuber, Ammar Tahir, Ya Chen, Elke H. Heiss, Thierry Langer, Johannes Kirchmair, Judith M. Rollinger. In Silico and In Vitro Approach to Assess Direct Allosteric AMPK Activators from Nature. Planta Medica 2022, 88 (09/10) , 794-804.
    78. Mohini Soni, J. Venkatesh Pratap. Development of Novel Anti-Leishmanials: The Case for Structure-Based Approaches. Pathogens 2022, 11 (8) , 950.
    79. Jorge Franco, Francesco Piacente, Melanie Walter, Simone Fratta, Moustafa Ghanem, Andrea Benzi, Irene Caffa, Alexander V. Kurkin, Andrea Altieri, Patrick Herr, Macarena Martínez-Bailén, Inmaculada Robina, Santina Bruzzone, Alessio Nencioni, Alberto Del Rio. Structure-Based Identification and Biological Characterization of New NAPRT Inhibitors. Pharmaceuticals 2022, 15 (7) , 855.
    80. Utid Suriya, Panupong Mahalapbutr, Thanyada Rungrotmongkol. Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site. Pharmaceutics 2022, 14 (7) , 1461.
    81. Natalia A. Szulc, Zuzanna Mackiewicz, Janusz M. Bujnicki, Filip Stefaniak, . fingeRNAt—A novel tool for high-throughput analysis of nucleic acid-ligand interactions. PLOS Computational Biology 2022, 18 (6) , e1009783.
    82. Joanna Matalińska, Piotr F.J. Lipiński. Correcting a widespread error: Neuroprotectant N-acetyl-L-tryptophan does not bind to the neurokinin-1 receptor. Molecular and Cellular Neuroscience 2022, 120 , 103728.
    83. Karishma Singh, Roger M. Coopoosamy, Njabulo J. Gumede, Saheed Sabiu. Computational Insights and In Vitro Validation of Antibacterial Potential of Shikimate Pathway-Derived Phenolic Acids as NorA Efflux Pump Inhibitors. Molecules 2022, 27 (8) , 2601.
    84. Dmitry A. Shulga, Nikita N. Ivanov, Vladimir A. Palyulin. In Silico Structure-Based Approach for Group Efficiency Estimation in Fragment-Based Drug Design Using Evaluation of Fragment Contributions. Molecules 2022, 27 (6) , 1985.
    85. Guan Wang, Jin Li, Xiao-Li Pan, Fa-Qian Bu, Yu-Meng Zhu, Ao-Xue Wang, Liang Ouyang. Discovery of Tyrosinase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation. Pharmaceutical Fronts 2022, 04 (01) , e1-e8.
    86. Alejandro Varela‐Rial, Maciej Majewski, Gianni De Fabritiis. Structure based virtual screening: Fast and slow. WIREs Computational Molecular Science 2022, 12 (2)
    87. Ibrahim Damilare Boyenle, Temitope Isaac Adelusi, Abdeen Tunde Ogunlana, Rofiat Adeyemi Oluwabusola, Najahtulahi Opeyemi Ibrahim, Ajao Tolulope, Ogundepo Sunday Okikiola, Bamigbade Lukman Adetunji, Ibraheem Omotayo Abioye, Abdul-Quddus Kehinde Oyedele. Consensus scoring-based virtual screening and molecular dynamics simulation of some TNF-alpha inhibitors. Informatics in Medicine Unlocked 2022, 28 , 100833.
    88. Yves L Janin. On drug discovery against infectious diseases and academic medicinal chemistry contributions. Beilstein Journal of Organic Chemistry 2022, 18 , 1355-1378.
    89. Assaf Alon, Jiankun Lyu, Joao M. Braz, Tia A. Tummino, Veronica Craik, Matthew J. O’Meara, Chase M. Webb, Dmytro S. Radchenko, Yurii S. Moroz, Xi-Ping Huang, Yongfeng Liu, Bryan L. Roth, John J. Irwin, Allan I. Basbaum, Brian K. Shoichet, Andrew C. Kruse. Structures of the σ2 receptor enable docking for bioactive ligand discovery. Nature 2021, 600 (7890) , 759-764.
    90. Francesco Gentile, Michael Fernandez, Fuqiang Ban, Anh-Tien Ton, Hazem Mslati, Carl F. Perez, Eric Leblanc, Jean Charle Yaacoub, James Gleave, Abraham Stern, Bill Wong, François Jean, Natalie Strynadka, Artem Cherkasov. Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules. Chemical Science 2021, 12 (48) , 15960-15974.
    91. Richard A. Lewis. Best practices for repurposing studies. Journal of Computer-Aided Molecular Design 2021, 35 (12) , 1189-1193.
    92. Fernando D. Prieto-Martínez, Eli Fernández-de Gortari, José L. Medina-Franco, L. Michel Espinoza-Fonseca. An in silico pipeline for the discovery of multitarget ligands: A case study for epi-polypharmacology based on DNMT1/HDAC2 inhibition. Artificial Intelligence in the Life Sciences 2021, 1 , 100008.
    93. Cédric Bouysset, Sébastien Fiorucci. ProLIF: a library to encode molecular interactions as fingerprints. Journal of Cheminformatics 2021, 13 (1)
    94. Matej Janežič, Katja Valjavec, Kaja Bergant Loboda, Barbara Herlah, Iza Ogris, Mirijam Kozorog, Marjetka Podobnik, Simona Golič Grdadolnik, Gerhard Wolber, Andrej Perdih. Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα. International Journal of Molecular Sciences 2021, 22 (24) , 13474.
    95. Simone Brogi, Vincenzo Calderone. Artificial Intelligence in Translational Medicine. International Journal of Translational Medicine 2021, 1 (3) , 223-285.
    96. Iryna O. Kravets, Dmytro V. Dudenko, Alexander E. Pashenko, Tatiana A. Borisova, Ganna M. Tolstanova, Sergey V. Ryabukhin, Dmitriy M. Volochnyuk. Virtual Screening in Search for a Chemical Probe for Angiotensin-Converting Enzyme 2 (ACE2). Molecules 2021, 26 (24) , 7584.
    97. Alberto Marbán-González, Armando Hernández-Mendoza, Mario Ordóñez, Rodrigo Said Razo-Hernández, José Luis Viveros-Ceballos. Discovery of Octahydroisoindolone as a Scaffold for the Selective Inhibition of Chitinase B1 from Aspergillus fumigatus: In Silico Drug Design Studies. Molecules 2021, 26 (24) , 7606.
    98. Mu-Yuan Yu, Si-Na Liu, Hui Liu, Qing-Hong Meng, Xu-Jie Qin, Hai-Yang Liu. Acylphloroglucinol trimers from Callistemon salignus seeds: Isolation, configurational assignment, hAChE inhibitory effects, and molecular docking studies. Bioorganic Chemistry 2021, 117 , 105404.
    99. Jonathan Dickerhoff, Kassandra R. Warnecke, Kaibo Wang, Nanjie Deng, Danzhou Yang. Evaluating Molecular Docking Software for Small Molecule Binding to G-Quadruplex DNA. International Journal of Molecular Sciences 2021, 22 (19) , 10801.
    100. Flavio Ballante, Albert J Kooistra, Stefanie Kampen, Chris de Graaf, Jens Carlsson, . Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?. Pharmacological Reviews 2021, 73 (4) , 1698-1736.
    Load all citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect